Genus plc GNS.L
GB · London Stock Exchange · XLON · stock · Healthcare · website
Genus plc statistics & valuation
Market cap£1.4B
P / E71.7×
P / S2.1×
P / B2.9×
P / FCF28.5×
Dividend yield1.53%
Net margin2.9%
Return on equity4.1%
FCF margin7.2%
Net debt£217.9M
Enterprise value USD$2.1B
Earnings yield EBIT/EV2.6%
Return on capital5.5%
Graham number -99.7%£6.31
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (£6.31); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | — | 26.7% | 27.2% | 24.9% |
| Operating margin | 6.3% | 1.0% | 6.4% | 8.7% |
| Net margin | 2.9% | 1.2% | 4.8% | 6.9% |
| FCF margin | 7.2% | 0.8% | 2.2% | -5.2% |
| Return on assets | 2.1% | 0.8% | 3.4% | 4.0% |
| Return on equity | 4.1% | 1.5% | 6.1% | 7.1% |
| Debt / equity | 0.45× | 0.44× | 0.36× | 0.32× |
| Current ratio | 1.94 | 1.80 | 1.76 | 1.70 |
Computed from company filings · GB · as of 2025-06-30. Figures in GBP. Facts plus Stocktoria's own computed scores — not investment advice.